Remedium Lifecare Limited (BOM:539561)

Remedium Lifecare Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	21.29	327.3	54.26	10.78	4.81
Depreciation & Amortization	0.39	0.57	1.51	0.74	0.6
Other Operating Activities	74.15	36.91	0.3	1.06	1.35
Change in Accounts Receivable	-7,716	-7,478	-1,084	-403.12	-221.85
Change in Inventory	-2,694	-1,259	765.52	-807.65	-24.07
Change in Accounts Payable	5,010	6,271	-403.45	1,008	233.85
Change in Other Net Operating Assets	-6,044	1,360	870.64	303.11	-96.82
Operating Cash Flow	-11,348	-741.61	205	112.83	-102.13
Operating Cash Flow Growth	-	-	81.69%	-	-
Capital Expenditures	-	-	-0.43	-0.5	-0.39
Other Investing Activities	1.29	0.94	-	-	-
Investing Cash Flow	1.29	0.94	-0.43	-0.5	-0.39
Short-Term Debt Issued	11,414	577.03	-	-	-
Long-Term Debt Issued	-	-	-	-	101.37
Total Debt Issued	11,414	577.03	-	-	101.37
Long-Term Debt Repaid	-	-	-	-105.01	-
Net Debt Issued (Repaid)	11,414	577.03	-	-105.01	101.37
Other Financing Activities	-52.89	-38.73	-0.37	-1.07	-
Financing Cash Flow	11,361	538.29	-0.37	-106.08	101.37
Miscellaneous Cash Flow Adjustments	-0	-0.94	-	-	-0
Net Cash Flow	14.27	-203.32	204.2	6.25	-1.14
Free Cash Flow	-11,348	-741.61	204.57	112.33	-102.51
Free Cash Flow Growth	-	-	82.12%	-	-
Free Cash Flow Margin	-280.03%	-1.84%	4.01%	2.23%	-11.39%
Free Cash Flow Per Share	-26.65	-1.84	0.51	0.28	-0.25
Cash Interest Paid	52.89	38.73	0.37	-	-
Cash Income Tax Paid	-	178.12	19.77	4.48	0.38
Levered Free Cash Flow	-10,887	-922.25	190.6	110.69	-103.49
Unlevered Free Cash Flow	-10,854	-897.1	191.05	111.13	-103.42
Change in Net Working Capital	10,848	1,106	-148.93	-100.25	107.76

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.